silicon laboratories inc. - SLAB
SLAB
Close Chg Chg %
205.22 1.28 0.62%
Closed Market
206.50
+1.28 (0.62%)
Volume: 1.75M
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: silicon laboratories inc. - SLAB
SLAB Key Data
| Open $205.81 | Day Range 205.53 - 208.84 |
| 52 Week Range 82.82 - 208.84 | Market Cap $6.68B |
| Shares Outstanding 32.85M | Public Float 32.10M |
| Beta 1.56 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$1.99 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 886.50K |
SLAB Performance
| 1 Week | 44.96% | ||
| 1 Month | 41.35% | ||
| 3 Months | 63.34% | ||
| 1 Year | 44.75% | ||
| 5 Years | 48.07% |
SLAB Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
About silicon laboratories inc. - SLAB
Silicon Laboratories, Inc. engages in providing and developing analog-intensive and mixed-signal integrated circuits. It focuses on wireless development platform and product portfolio for the internet of things based on Bluetooth, sub-GHz proprietary technologies, Wi-SUN, Thread, Wi-Fi, Zigbee, and Z-Wave. The company was founded by Navdeep S. Sooch, David R. Welland, and Jeffrey W. Scott in August 1996 and is headquartered in Austin, TX.
SLAB At a Glance
Silicon Laboratories, Inc.
400 West Cesar Chavez
Austin, Texas 78701-3883
| Phone | 1-512-416-8500 | Revenue | 584.39M | |
| Industry | Semiconductors | Net Income | -191,010,000.00 | |
| Sector | Electronic Technology | Employees | N/A | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
SLAB Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 7.039 |
| Price to Book Ratio | 3.84 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -32.10 |
| Enterprise Value to Sales | 6.421 |
| Total Debt to Enterprise Value | 0.006 |
SLAB Efficiency
| Revenue/Employee | 309,362.626 |
| Income Per Employee | -101,116.993 |
| Receivables Turnover | 10.727 |
| Total Asset Turnover | 0.438 |
SLAB Liquidity
| Current Ratio | 6.151 |
| Quick Ratio | 5.071 |
| Cash Ratio | 3.904 |
SLAB Profitability
| Gross Margin | 49.48 |
| Operating Margin | -28.319 |
| Pretax Margin | -26.492 |
| Net Margin | -32.686 |
| Return on Assets | -14.331 |
| Return on Equity | -16.692 |
| Return on Total Capital | -17.342 |
| Return on Invested Capital | -16.437 |
SLAB Capital Structure
| Total Debt to Total Equity | 1.984 |
| Total Debt to Total Capital | 1.945 |
| Total Debt to Total Assets | 1.752 |
| Long-Term Debt to Equity | 1.44 |
| Long-Term Debt to Total Capital | 1.412 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Silicon Laboratories Inc. - SLAB
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 720.86M | 1.02B | 782.26M | 584.39M | |
Sales Growth
| -18.70% | +42.07% | -23.62% | -25.29% | |
Cost of Goods Sold (COGS) incl D&A
| 339.97M | 415.62M | 347.05M | 295.23M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 62.56M | 56.59M | 51.08M | 48.59M | |
Depreciation
| 18.05M | 22.52M | 25.71M | 25.55M | |
Amortization of Intangibles
| 44.51M | 34.07M | 25.37M | 23.03M | |
COGS Growth
| -15.82% | +22.25% | -16.50% | -14.93% | |
Gross Income
| 380.89M | 608.49M | 435.21M | 289.15M | |
Gross Income Growth
| -21.11% | +59.75% | -28.48% | -33.56% | |
Gross Profit Margin
| +52.84% | +59.42% | +55.64% | +49.48% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 413.73M | 489.23M | 459.37M | 454.64M | |
Research & Development
| 240.89M | 303.36M | 312.45M | 309.23M | |
Other SG&A
| 172.84M | 185.86M | 146.92M | 145.41M | |
SGA Growth
| -6.43% | +18.25% | -6.10% | -1.03% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | 3.37M | 3.40M | - |
EBIT after Unusual Expense
| (36.21M) | 115.86M | (24.15M) | (165.49M) | |
Non Operating Income/Expense
| 5.70M | 13.91M | 19.16M | 11.99M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 27.66M | 3.32M | 5.55M | 1.31M | |
Interest Expense Growth
| -8.04% | -87.99% | +67.14% | -76.41% | |
Gross Interest Expense
| 27.66M | 3.32M | 5.55M | 1.31M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (58.17M) | 126.45M | (10.54M) | (154.81M) | |
Pretax Income Growth
| -480.20% | +317.36% | -108.34% | -1,368.40% | |
Pretax Margin
| -8.07% | +12.35% | -1.35% | -26.49% | |
Income Tax
| 13.43M | 38.45M | 7.94M | 36.20M | |
Income Tax - Current - Domestic
| (12.63M) | 52.83M | 3.29M | (252.00K) | |
Income Tax - Current - Foreign
| 9.45M | 3.86M | 15.60M | 6.98M | |
Income Tax - Deferred - Domestic
| 17.87M | (17.73M) | (9.04M) | 29.75M | |
Income Tax - Deferred - Foreign
| (1.26M) | (512.00K) | (1.91M) | (274.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (57.87M) | 91.40M | (34.52M) | (191.01M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (57.87M) | 91.40M | (34.52M) | (191.01M) | |
Net Income Growth
| -561.85% | +257.93% | -137.76% | -453.40% | |
Net Margin Growth
| -8.03% | +8.93% | -4.41% | -32.69% | |
Extraordinaries & Discontinued Operations
| - | - | - | (247.89M) | - |
Discontinued Operations
| - | - | - | (247.89M) | - |
Net Income After Extraordinaries
| (305.76M) | 91.40M | (34.52M) | (191.01M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (305.76M) | 91.40M | (34.52M) | (191.01M) | |
EPS (Basic)
| -7.139 | 2.6051 | -1.0853 | -5.9336 | |
EPS (Basic) Growth
| -2,593.54% | +136.49% | -141.66% | -446.72% | |
Basic Shares Outstanding
| 42.83M | 35.09M | 31.80M | 32.19M | |
EPS (Diluted)
| -7.139 | 2.536 | -1.0853 | -5.9336 | |
EPS (Diluted) Growth
| -2,627.97% | +135.52% | -142.80% | -446.72% | |
Diluted Shares Outstanding
| 42.83M | 36.04M | 31.80M | 32.19M | |
EBITDA
| 29.72M | 175.85M | 26.93M | (116.91M) | |
EBITDA Growth
| -71.19% | +491.75% | -84.69% | -534.16% | |
EBITDA Margin
| +4.12% | +17.17% | +3.44% | -20.00% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 192.50 | |
| Number of Ratings | 12 | Current Quarters Estimate | 0.503 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 2.705 | |
| Last Quarter’s Earnings | 0.56 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.92 | Next Fiscal Year Estimate | 4.141 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 10 | 10 | 10 | 8 |
| Mean Estimate | 0.50 | 0.65 | 2.71 | 4.14 |
| High Estimates | 0.59 | 0.75 | 3.00 | 4.58 |
| Low Estimate | 0.44 | 0.59 | 2.50 | 3.75 |
| Coefficient of Variance | 9.23 | 8.63 | 5.05 | 6.78 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 5 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 11 | 6 | 4 |
| UNDERWEIGHT | 0 | 1 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Overweight | Overweight |
SEC Filings for Silicon Laboratories Inc. - SLAB
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Silicon Laboratories Inc. - SLAB
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Dec 9, 2025 | Brandon Tolany Sr VP WW Sales & Marketing | 62,381 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $140.17 per share | 8,743,944.77 |
| Dec 9, 2025 | Brandon Tolany Sr VP WW Sales & Marketing | 64,335 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $43.82 per share | 2,819,159.70 |
| Dec 9, 2025 | Brandon Tolany Sr VP WW Sales & Marketing | 62,381 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $141.49 per share | 8,826,287.69 |
| Dec 9, 2025 | Brandon Tolany Sr VP WW Sales & Marketing | 1,954 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Dec 9, 2025 | Brandon Tolany Sr VP WW Sales & Marketing | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Dec 9, 2025 | Brandon Tolany Sr VP WW Sales & Marketing | 66,627 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $43.82 per share | 2,919,595.14 |
| May 20, 2025 | Dean W. Butler Sr VP and CFO | 38,696 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.17 per share | 5,153,146.32 |
| May 20, 2025 | Dean W. Butler Sr VP and CFO | 42,844 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Dean W. Butler Sr VP and CFO | 28,113 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $86.46 per share | 2,430,649.98 |
| May 20, 2025 | R. Matthew Johnson President & CEO; Director | 73,688 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $131.2 per share | 9,667,865.60 |
| May 20, 2025 | R. Matthew Johnson President & CEO; Director | 79,567 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.17 per share | 10,595,937.39 |
| May 20, 2025 | R. Matthew Johnson President & CEO; Director | 87,192 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Mark D. Mauldin Chief Accounting Officer | 19,112 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.17 per share | 2,545,145.04 |
| May 20, 2025 | Mark D. Mauldin Chief Accounting Officer | 19,990 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Mark D. Mauldin Chief Accounting Officer | 17,534 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $86.46 per share | 1,515,989.64 |
| May 20, 2025 | Robert J. Conrad Sr VP and General Manager | 25,380 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $131.2 per share | 3,329,856.00 |
| May 20, 2025 | Robert J. Conrad Sr VP and General Manager | 29,409 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.17 per share | 3,916,396.53 |
| May 20, 2025 | Robert J. Conrad Sr VP and General Manager | 30,704 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Robert J. Conrad Sr VP and General Manager | 20,883 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 7, 2025 | Navdeep S. Sooch Director | 400,567 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $149 per share | 59,684,483.00 |